Gryphon Financial Partners’s Juno Therapeutics, Inc. JUNO Stock Holding History

Gryphon Financial Partners’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-50	Closed	-$2K	–	1061
2017 Q4	$2K	Buy	+50	New	+$2.49K	﹤0.01%	941

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Gryphon Financial Partners's JUNO Position: Q1 2018 in Review

Gryphon Financial Partners sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 50 shares — an estimated $2K sold.

Gryphon Financial Partners first reported a position in JUNO in Q4 2017 and held it in 1 quarter. The position peaked at $2K in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Gryphon Financial Partners reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Gryphon Financial Partners sold 50 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $2K.
Gryphon Financial Partners first reported a position in Juno Therapeutics, Inc. in Q4 2017 and held it in 1 quarter.
Gryphon Financial Partners's Juno Therapeutics, Inc. position peaked at $2K in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Gryphon Financial Partners's 13F filing for Q1 2018, filed 14 May 2018.